The Investment Column: Galen
Friday 21 May 1999
Although Galen's business is dominated by the supply to other pharmaceuticals companies of services for clinical trials, it also has new products ready for next year. Its prospects depend on keeping its edge in trial services and demand for its new products.
Yesterday's results justified the recovery in its shares from 360p to 542.5p. After a 59 per cent hike in clinical trial services turnover to pounds 12.1m, first-half group sales jumped 29 per cent to pounds 31m. Pre-tax profits soared 26 per cent to pounds 9.5m.
Galen's task is to sustain this growth in the services market, but it's not obvious that it has distinctive abilities. The competition is hotting up. Long-term sales growth for the products division, which makes analgesics and antibiotics, is not guaranteed either. Sales grew by 15 per cent in the half year but Galen expects sales to take off as it attacks the pounds 2.5bn global hormone replacement therapy market with an intravaginal ring, an alternative way of delivering hormone replacement therapy to pills and skin patches.
Galen is confident of finding a global distribution partner following the failure of its merger with Ferring, the Dutch pharmaceuticals group. But assessments of the product's potential market vary from very little to millions of pounds annually.
Housebroker ABN Amro is forecasting pre-tax profits of pounds 18.5m for the full-year, with earnings of 11.7p. That puts Galen on a racy forward earnings multiple of 46 times. That looks expensive for a company yet to prove it can sustain its performance and investors should consider taking profits.
- 1 President of Argentina adopts Jewish godson to 'stop him turning into a werewolf'
- 3 Sir Winston Churchill’s family begged him not to convert to Islam, letter reveals
- 4 UK weather: 'Coldest night of the year' tonight as freezing temperatures plummet to -10C
- 5 Game of Thrones is most-pirated TV show of 2014
President of Argentina adopts Jewish godson to 'stop him turning into a werewolf'
Exclusive: Abusers using spyware apps to monitor partners reaches 'epidemic proportions'
Stoke-on-Trent becomes first British city to be classified as 'disaster resilient' by the United Nations
Sir Winston Churchill’s family begged him not to convert to Islam, letter reveals
AirAsia flight QZ8501 missing: Search for plane carrying 162 passengers from Indonesia to Singapore suspended overnight
Millions of Britons struggling to feed themselves and facing malnourishment
British actor Idris Elba cannot star as James Bond because he is black, says shock jock Rush Limbaugh
Ukip member gets into Christmas spirit with Union Flag plea to Santa 'for our country back'
Germany anti-Islam protests: 17,000 march on Dresden against 'Islamification of the West'
Nigel Farage: Ukip leader named 'Briton of the year' by The Times
Immigrants make UK racist, says Ukip councillor Trevor Shonk
iJobs Money & Business
Not specified: Selby Jennings: VP/SVP Credit Quant Top tier investment bank i...
Not specified: Selby Jennings: Quantitative Research | Global Equity | New Yor...
Not specified: Selby Jennings: SVP Model Validation This top tiered investment...
Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...